Skip to main content
Stewart Tepper, MD, Neurology, Stamford, CT

Stewart J. Tepper MD

Headache


Vice President, The New England Institute for Neurology and Headache

Join to view full profile
  • 30 Buxton Farm RdSte 230Stamford, CT 06905

  • Phone+1 203-914-1900

Dr. Tepper is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1981 - 1984
  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1981 - 1984
  • University of Washington School of Medicine
    University of Washington School of MedicineJunior Residency, 1980 - 1981
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 1979 - 1980
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1979

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1999 - 2028
  • CT State Medical License
    CT State Medical License 1999 - 2027
  • PA State Medical License
    PA State Medical License 2023 - 2024
  • VT State Medical License
    VT State Medical License 2022 - 2024
  • NH State Medical License
    NH State Medical License 2015 - 2023
  • OH State Medical License
    OH State Medical License 2008 - 2017
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018  
    Stewart Tepper, MD, Headache: The Journal of Head and Face Pain
  • Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker  
    Dawn C Buse, Stewart J Tepper, David W Dodick, Headache: The Journal of Head and Face Pain
  • Migraine: barriers for care.  
    Sheftell FD, Tepper SJ, Bigal ME, Neurol Sci. 2005;26 Suppl 2:s140-2

Books/Book Chapters

Abstracts/Posters

  • Botulinum Toxin in the Preventive Treatment of Refractory Headaches.
    Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM, International Headache Research Seminars, Copenhagen, Denmark
  • Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)—a case report.
    Volcy M, Tepper SJ, Rapoport AM, Sheftell FD, Bigal MD, Cephalalgia 2005:25:470–472
  • Rational Therapy for Headache.
    Cady RK, Rosum RW, Solomon GD, Tepper SJ, Institute for Contemporary Pharmacy Research

Lectures

  • Prevention of Headache Recurrence, Migraine. 
    American Academy of Neurology, Boston, MA
  • Pathophysiology and Pharmacology of Migraine. 
    XVI Annual US Army Medical Department Neurology Conference. Madigan Army Medical Center, Tacoma, WA
  • When should we use 5HT agonists and when might they be used in preference to other treatments such as ergotamines and combination therapies, in New Horizons in Migraine. 
    XVIth World Congress of Neurology, Buenos Aires, Argentina

Other

  • Migraine: improved outcomes in patients previously poorly responsive to therapy. 
    Dowson AJ and Tepper SJ, Int J Clinic Practice 2008;62(12):1822-1824
  • Rescue Me: Rescue Medication for Migraine. 
    Whyte C, Tepper SJ, Evans R, Headache 2010;50(2):307-313
  • Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter? 
    Katic´ BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME, Headache 2010;50(1):117-132

Press Mentions

  • Lundbeck Advances Leadership in Migraine with New Data at the American Headache Society 67th Annual Scientific Meeting
    Lundbeck Advances Leadership in Migraine with New Data at the American Headache Society 67th Annual Scientific MeetingJune 19th, 2025
  • FDA Okays Dihydroergotamine Nasal Spray for Acute Migraine
    FDA Okays Dihydroergotamine Nasal Spray for Acute MigraineMay 5th, 2025
  • FDA Approves Atzumi Nasal Powder for Acute Migraine Treatment
    FDA Approves Atzumi Nasal Powder for Acute Migraine TreatmentMay 2nd, 2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: